by Elena Iemma | Dec 19, 2024 | Uncategorized
Even more Fearless in 2025 2024 was a year of transformation and momentum for us—a real steppingstone to EpiVax 2.0. We are grateful to our new CEO, Rich-Henry Schabowsky, for creating a work environment where innovation moves at a human pace. Because together, we...
by Elena Iemma | Dec 9, 2024 | News
EpiVax Drives Immunogenicity Innovation in 2024: Year in Review PROVIDENCE, R.I., Dec. 6, 2024 — EpiVax, Inc., a leader in preclinical immunogenicity risk assessment for biologic and peptide therapeutics, celebrates a productive 2024 marked by...
by Elena Iemma | Dec 6, 2024 | News
PROVIDENCE, R.I., Dec. 6, 2024 — EpiVax, a leader in biotechnology known for its advanced immunoinformatics tools, proudly announces its continued support for two nonprofits, Clínica Esperanza/Hope Clinic and GAIA Vaccine Foundation....
by Elena Iemma | Dec 4, 2024 | Events
Tentative date: June 5 & 6, 2025 9:00am – 5:00pm (with receptions to follow!) 350 Eddy St. Providence, RI 02903 Save the Date The second Artificial Intelligence / Human Intelligence Workshop is tentatively planned for June 5 and 6th at the South Street...
by Elena Iemma | Nov 19, 2024 | Uncategorized
Talking out loud to myself (and about 7000 friends) It’s the time of year for gratitude As we approach the season of gratitude, I would like to THANK YOU, our colleagues in the immunogenicity space, who are “Science Forward”....
